Edition:
United States

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

750.25INR
25 Jul 2017
Change (% chg)

-- (--)
Prev Close
Rs750.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,054,768
52-wk High
Rs895.00
52-wk Low
Rs503.05

Select another date:

Wed, Jul 19 2017

Indian shares close higher; Aurobindo Pharma leads

July 19 Indian shares recovered on Wednesday as cigarette maker ITC rebounded and drugmakers gained on hopes of U.S. regulatory approvals and the launches of new drugs.

BRIEF-Aurobindo Pharma gets USFDA approval for Sevelamer Carbonate tablets

* Says Aurobindo Pharma receives USFDA approval for Sevelamer Carbonate tablets

BRIEF-Aurobindo Pharma gets USFDA approval for drug for treating chronic kidney disease

* Aurobindo Pharma - receives USFDA approval for Sevelamer Carbonate Oral Suspension

BRIEF-Aurobindo Pharma gets FDA nod for generic ADHD drug

* Says Aurobindo Pharma receives USFDA approval for atomoxetine capsules

Indian shares edge up to record closes; Aurobindo Pharma surges

May 30 Indian shares rose for a fourth straight session to hit record closing highs, as Aurobindo Pharma jumped after saying it would not be too impacted by price erosion in the U.S. market, and sentiment was boosted by the arrival of monsoon rains.

BRIEF-Aurobindo Pharma expects U.S. drug price erosion to continue for at least another 4 qtrs - exec

* Exec says expects U.S. drug price erosion to continue for at least another four quarters

BRIEF-Aurobindo Pharma says US FDA issued form 483 with 6 observations for unit-III

* Clarifies on news item "US FDA issues 5-6 'largely procedural' observations to Aurobindo Pharma's Unit-III"

BRIEF-Aurobindo Pharma gets FDA nod for generic drug to treat HIV-1 infection

* Says Aurobindo Pharma receives USFDA approval for generic Epzicom tablets

BRIEF-Aurobindo Pharma gets USFDA nod for Meropenem injection

* Meropenem injection is a generic equivalent of Astrazeneca Pharma's Merrem injection

BRIEF-Aurobindo Pharma gets FDA nod for generic version of Reckitt Benckiser’s Mucinex DM tablets

* Says Aurobindo Pharma receives USFDA approval for guaifenesin and dextromethorphan hydrobromide

Select another date: